Evidence map›Paper›PMID 41723544›Full record

ArticleGut pathogens2026

Epithelial cell-derived exosomes carry NamiRNA-143-5p and promote ASPN expression in fibroblasts to induce Helicobacter pylori infected gastritis progression.

Zheng Zhang, Shuyue Yang, Mengran Zhao, Wenjing Sun, Rui Xu, Anni Zhou, Sifan Liu, Mingyang Ma, Peng Li

Abstract read
In one paragraph

Article in Gut pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zheng Zhang *Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, State Key Laboratory of Digestive Health, National Clinical Research Center for Digestive Disease, Beijing Key Laboratory of Early Gastrointestinal Cancer Medicine and Medical Devices, Beijing, 100050, P.R. China. tianzece@163.com.
Shuyue Yang *Department of Gastroenterology, Tianjin Union Medical Center, the First Affiliated Hospital of Nankai University, Tianjin, 300121, China.
Mengran ZhaoDepartment of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, State Key Laboratory of Digestive Health, National Clinical Research Center for Digestive Disease, Beijing Key Laboratory of Early Gastrointestinal Cancer Medicine and Medical Devices, Beijing, 100050, P.R. China.
Wenjing SunDepartment of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, State Key Laboratory of Digestive Health, National Clinical Research Center for Digestive Disease, Beijing Key Laboratory of Early Gastrointestinal Cancer Medicine and Medical Devices, Beijing, 100050, P.R. China.
Rui XuDepartment of Pathology, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, P.R. China.
Anni ZhouDepartment of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, State Key Laboratory of Digestive Health, National Clinical Research Center for Digestive Disease, Beijing Key Laboratory of Early Gastrointestinal Cancer Medicine and Medical Devices, Beijing, 100050, P.R. China.
Sifan LiuDepartment of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, State Key Laboratory of Digestive Health, National Clinical Research Center for Digestive Disease, Beijing Key Laboratory of Early Gastrointestinal Cancer Medicine and Medical Devices, Beijing, 100050, P.R. China.
Mingyang MaDepartment of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, State Key Laboratory of Digestive Health, National Clinical Research Center for Digestive Disease, Beijing Key Laboratory of Early Gastrointestinal Cancer Medicine and Medical Devices, Beijing, 100050, P.R. China.
Peng LiDepartment of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, State Key Laboratory of Digestive Health, National Clinical Research Center for Digestive Disease, Beijing Key Laboratory of Early Gastrointestinal Cancer Medicine and Medical Devices, Beijing, 100050, P.R. China. lipeng@ccmu.edu.cn.

Funding

National Natural Science Foundation of China 82200622Natural Science Foundation of Beijing Municipality 2332028
6 · The paper itself

Abstract

In Helicobacter pylori (H. pylori) associated gastritis, fibroblasts are recruited to inflammatory sites and secrete multiple pro-inflammatory cytokines, but the underlying mechanism remains unclear. Here, immunohistochemical staining revealed that ASPN expression was significantly upregulated in fibroblasts from H. pylori positive gastritis tissues, whereas its level remained unchanged in fibroblasts directly infected with H. pylori. Co-culture assays demonstrated that exosomes released from H. pylori infected epithelial cells induced the upregulation of ASPN and its downstream cytokines (IL-4, IL-6, and TGF-β) in fibroblasts. MicroRNA sequencing and correlation analyses identified miR-143-5p as an exosomal miRNA enriched after H. pylori infection that potentially regulates ASPN. Immunofluorescence confirmed that exosomes derived from epithelial cells carrying miR-143-5p were internalized by fibroblasts. Further immunofluorescence and immunohistochemical analyses showed nuclear accumulation of miR-143-5p in fibroblasts in both the H. pylori infected epithelial cell co-culture system and H. pylori positive gastritis tissues. Mechanistic studies demonstrated that miR-143-5p functions as a nuclear activating microRNA (NamiRNA-143-5p), binding to the super-enhancer region of ASPN, increasing H3K27ac enrichment, and promoting its transcription. In vivo, antagomir-143-5p reduced H. pylori induced ASPN and cytokine overexpression, thereby alleviating gastric inflammation. Thus, we conclude that exosomal NamiRNA-143-5p from H. pylori infected epithelial cells upregulate pro-inflammatory cytokines in fibroblasts by activating ASPN expression through a super-enhancer-dependent pathway, thereby positioning this axis as a potential therapeutic target for H. pylori associated gastric disease.

Indexed as

ASPNExosomeFibroblastHelicobacter pyloriNamiRNA

Identifiers

PMID41723544
PMCPMC13220442

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.